Aditxt Inc. Proposes Corporate Name Change to bitXbio as Part of Blockchain Integration Strategy

Aditxt Inc. (NASDAQ: ADTX) has unveiled its comprehensive bitXbio strategy, a framework designed to bridge public markets, blockchain and Web3 technologies, and digital asset treasuries to support breakthrough health innovations through a participation-driven model. The company filed a Preliminary Proxy Statement seeking shareholder approval for multiple proposals that would fundamentally reshape its corporate identity and operational approach.

The proposed changes include an Employee Stock Purchase Plan intended to strengthen employee-shareholder alignment and support the company's long-term growth vision. Additionally, Aditxt is seeking a non-binding advisory vote to amend its Certificate of Incorporation to change its corporate name to bitXbio, Inc. This name change reflects the company's planned evolution into a platform that links digital assets with life sciences ventures, marking a significant shift in its strategic direction.

Aditxt describes itself as a social innovation platform accelerating health-focused technologies, with its ecosystem comprising research institutions, industry partners, and shareholders collaboratively driving its mission to "Make Promising Innovations Possible Together." The company's innovation platform serves as the cornerstone of its strategy, where multiple disciplines drive disruptive growth and address significant societal challenges in healthcare.

The company currently operates four distinct programs focused on critical health areas: autoimmunity, cancer and early disease detection, infectious diseases, and women's health. Aditxt's unique operational model emphasizes democratizing innovation, ensuring every stakeholder's voice is heard and valued, and empowering collective progress across these healthcare domains.

The bitXbio strategy represents a forward-looking approach to integrating emerging technologies with traditional life sciences ventures. By connecting public markets with blockchain and Web3 technologies, the company aims to create new pathways for funding and developing health innovations. This integration could potentially transform how health technologies are funded, developed, and brought to market, leveraging the transparency and accessibility features of blockchain technology.

For investors and stakeholders, these developments signal Aditxt's commitment to positioning itself at the intersection of digital innovation and healthcare advancement. The proposed changes come at a time when both blockchain technology and digital assets are gaining increased recognition across various industries, including healthcare and life sciences. The company's latest news and updates relating to ADTX are available in the company's newsroom at https://ibn.fm/ADTX.

The broader implications of this strategic shift extend beyond corporate branding, potentially influencing how other life sciences companies approach funding models and technology integration. As healthcare continues to embrace digital transformation, Aditxt's bitXbio strategy could serve as a blueprint for combining traditional biomedical research with cutting-edge financial and technological innovations.